Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Charles River, Metabolon in Biomarker Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News

Charles River, Metabolon in Biomarker Partnership

Will offer biomarker identification services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Discovery Services has entered into an oncology biomarker research collaboration with Metabolon. The partnership combines Charles River’s preclinical oncology study expertise with Metabolon’s analysis of metabolic data to identify both mechanism of action and biomarkers.

Metabolon’s customized Metabolomics platform allows for quick validation of ideas and biomarker identification of mechanism of action. Together the companies will provide: elucidation, identification, characterization, and validation of drug target candidates, preclinical studies using validated in vitro and in vivo models, PK/PD, tumor growth delay, tumor growth inhibition, survival, combination and adjuvant study designs, assessment of lead chemistries, lead ID, optimal dose, optimal combinations, sensitivity/resistance patterns, and new indications for existing compounds, and development of biomarkers for preclinical PD, patient stratification/selection, translational models and efficacy.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics